Citalopram hydrobromide and Prednisolone drug interactions - from FDA reports


Drug interactions are reported among people who take Citalopram hydrobromide and Prednisolone together. This study is created by eHealthMe based on reports of 395 people who take Citalopram hydrobromide and Prednisolone from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Dec, 26, 2018

395 people who take Citalopram hydrobromide, Prednisolone are studied.


Number of reports submitted per year:

Citalopram hydrobromide and Prednisolone drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Thrombocytopenia (decrease of platelets in blood)
  2. Anaemia (lack of blood)
  3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  5. International normalised ratio increased
  6. Multi-organ failure (multisystem organ failure)
  7. Nephropathy (damage to or disease of a kidney)
  8. Pulmonary alveolar haemorrhage (acute bleeding)
  9. Urinary retention (the inability to completely or partially empty the bladder)
  10. Blood pressure increased
1 - 6 months:
  1. Hair growth abnormal
  2. Headache (pain in head)
  3. Hepatic trauma (liver injury)
  4. Hepatitis (inflammation of the liver)
  5. Hepatitis d
  6. Hyperbilirubinaemia (excess of bilirubin in the blood)
  7. Lethargy (tiredness)
  8. Leukopenia (less number of white blood cells in blood)
  9. Melaena (the passage of black, tarry stools)
  10. Neutropenia (an abnormally low number of neutrophils)
6 - 12 months:
  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Spinal cord compression
  4. Death
  5. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  6. Liver function test abnormal
  7. Thrombocytopenia (decrease of platelets in blood)
1 - 2 years:
  1. Anaemia (lack of blood)
  2. International normalised ratio increased
  3. Multi-organ failure (multisystem organ failure)
  4. Pulmonary alveolar haemorrhage (acute bleeding)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood)
  7. Tumour flare (temporary increase in symptoms from a cancer after starting treatment)
2 - 5 years:
  1. Anaemia (lack of blood)
  2. Blood cholesterol abnormal
  3. Blood triglycerides increased
  4. Death
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Dysarthria (speech disorder)
  7. Headache (pain in head)
  8. Hypertension (high blood pressure)
  9. Ketoacidosis (high concentrations of ketone bodies in blood)
  10. Leukopenia (less number of white blood cells in blood)
5 - 10 years:

n/a

10+ years:
  1. Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
  2. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  3. General physical health deterioration (weak health status)
  4. Headache (pain in head)
  5. Injection site erythema (redness at injection site)
  6. Injection site pruritus (severe itching at injection site)
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Migraine (headache)
  9. Muscle atrophy (a decrease in the mass of the muscle)
  10. Nasopharyngitis (inflammation of the nasopharynx)
not specified:
  1. Dyspnoea (difficult or laboured respiration)
  2. Pneumonia
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Dizziness
  6. Anaemia (lack of blood)
  7. Pain
  8. Pain in extremity
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Asthenia (weakness)

Most common drug interactions by gender *:

female:
  1. Fatigue (feeling of tiredness)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Renal failure (kidney dysfunction)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Infection
  6. Pain
  7. Alopecia (absence of hair from areas of the body)
  8. C-reactive protein increased
  9. Death
  10. Confusional state
male:
  1. Dyspnoea (difficult or laboured respiration)
  2. Pneumonia
  3. Back pain
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Vision blurred
  6. Anaemia (lack of blood)
  7. Arthralgia (joint pain)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. General physical health deterioration (weak health status)
  10. Overdose

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:
  1. Cardiac arrest
  2. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
30-39:
  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Adverse event
  3. Asthenia (weakness)
  4. Agoraphobia (extreme or irrational fear of crowded spaces or enclosed public places)
  5. Drug intolerance (drug sensitivity)
  6. Dyspnoea (difficult or laboured respiration)
  7. Erectile dysfunction
  8. Hallucination, auditory (perceiving sounds without auditory stimulus)
  9. Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
  10. Hypoacusis (loss of hearing)
40-49:
  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Leukopenia (less number of white blood cells in blood)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Diffuse large b-cell lymphoma stage ii (cancer of b cells, a type of white blood cell-stage ii)
  6. Anaphylactic reaction (serious allergic reaction)
  7. Lymphocele (a collection of lymphatic fluid within the body not bordered by epithelial lining)
  8. Overdose
  9. Ureteric obstruction
  10. Urticaria (rash of round, red welts on the skin that itch intensely)
50-59:
  1. Confusional state
  2. Abnormal behaviour
  3. Death
  4. Dizziness
  5. Fall
  6. Nephropathy (damage to or disease of a kidney)
  7. General physical health deterioration (weak health status)
  8. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  9. Facial paresis (weakness in facial muscle movement)
  10. Herpes zoster
60+:
  1. Anaemia (lack of blood)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Vision blurred
  4. Unresponsive to stimuli
  5. Arthralgia (joint pain)
  6. Chest pain
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Back pain
  9. Electrocardiogram qt prolonged
  10. Pain

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study



Do you take Citalopram hydrobromide and Prednisolone?


You are not alone:




Related studies

Citalopram hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Citalopram hydrobromide 28,839 users)

Prednisolone

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. (latest outcomes from Prednisolone 118,633 users)


Browse by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Citalopram hydrobromide and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Prednisolone and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Citalopram hydrobromide and Prednisolone
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Citalopram hydrobromide and Prednisolone (31,711 reports studied)

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!